Valuation: BOIRON

Market Cap 438M 502M 413M 375M 703M 48.15B 706M 4.95B 1.91B 24.48B 1.88B 1.84B 78.76B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 390M 447M 368M 334M 626M 42.88B 629M 4.41B 1.7B 21.8B 1.68B 1.64B 70.15B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day-1.25%
3 months-1.25%
6 months+5.00%
Current year+5.00%
Current year 31.5
Extreme 31.5
31.9
1 year 30
Extreme 30
32.28
3 years 24
Extreme 24
46.22
5 years 24
Extreme 24
53.5
10 years 24
Extreme 24
99.25
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2025
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 65 01/07/2011
Director/Board Member 54 10/03/2010
Director/Board Member 51 23/05/2013
Change 5-day change 1-year change 3-year change Capi.($)
-1.25%-.--% - - 502M
-0.66%+1.29%-13.43%-4.54% 13.67B
0.00%-2.03%-33.85%-56.71% 4.75B
-0.68%-1.86%-4.96%-6.97% 4.34B
+0.53%-1.43%-9.63%-32.11% 3.77B
+0.16%-1.25%-1.83%-3.85% 3.46B
+1.38%-1.43%-22.34%-1.00% 3.39B
-0.57%-1.98%-12.88%-2.39% 3.11B
-0.62%-0.82%-23.04%-18.69% 2.26B
+0.52%-1.97%-29.31%-21.61% 1.63B
Average -0.12%-0.83%-16.81%-16.43% 4.49B
Weighted average by Cap. -0.19%-0.59%-15.46%-14.47%

Financials

2024 2025
Net sales 488M 559M 460M 418M 783M 53.65B 787M 5.51B 2.13B 27.28B 2.1B 2.05B 87.77B 501M 575M 473M 430M 805M 55.14B 808M 5.67B 2.19B 28.03B 2.16B 2.11B 90.21B
Net income 11.34M 13M 10.7M 9.72M 18.21M 1.25B 18.29M 128M 49.48M 634M 48.83M 47.75M 2.04B 32.64M 37.43M 30.82M 27.99M 52.44M 3.59B 52.66M 369M 142M 1.83B 141M 138M 5.88B
Net Debt -49.74M -57.04M -46.96M -42.65M -79.9M -5.47B -80.24M -563M -217M -2.78B -214M -210M -8.95B -47.86M -54.88M -45.19M -41.03M -76.88M -5.27B -77.2M -541M -209M -2.68B -206M -202M -8.61B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!